ID

15956

Beskrivning

Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX); ODM derived from: https://clinicaltrials.gov/show/NCT02304354

Länk

https://clinicaltrials.gov/show/NCT02304354

Nyckelord

  1. 2016-06-21 2016-06-21 -
Uppladdad den

21 juni 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Rheumatoid Arthritis NCT02304354

Eligibility Rheumatoid Arthritis NCT02304354

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
ra according to the american college of rheumatology (acr) criteria
Beskrivning

Rheumatoid Arthritis

Datatyp

boolean

Alias
UMLS CUI [1]
C0003873
treatment with adalimumab in accordance to the spc
Beskrivning

Therapeutic procedure adalimumab

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1122087
disease modifying anti rheumatic drugs (dmards) prescribed since 3 months and stable 4 weeks before enrollment and during 16 weeks.
Beskrivning

Antirheumatic Drugs, Disease-Modifying

Datatyp

boolean

Alias
UMLS CUI [1]
C0242708
signed consent
Beskrivning

Informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
no anti tnf-alpha failure
Beskrivning

anti-tumor necrosis factor therapy failed | Absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0281481
UMLS CUI [1,2]
C0231175
UMLS CUI [2]
C0332197
previous rituximab treatment
Beskrivning

Prior Therapy rituximab

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0393022
contraindication to adalimumab, methotrexate or methylprednisolone
Beskrivning

Medical contraindication adalimumab | Medical contraindication Methotrexate | Medical contraindication Methylprednisolone

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1122087
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0025677
UMLS CUI [3,1]
C1301624
UMLS CUI [3,2]
C0025815
methotrexate-naive patient
Beskrivning

Therapy naive Methotrexate

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0919936
UMLS CUI [1,2]
C0025677
any hematologic disease affecting the lymphocytes (in particular lymphomas)
Beskrivning

Hematological Disease Affecting Lymphocyte | Hematological Disease Affecting Lymphoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0018939
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0024264
UMLS CUI [2,1]
C0018939
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0024299
any osteo-articular disease which could interfere with the interpretation of the influence of the rituximab on ra
Beskrivning

Disease osteoarticular Interferes with research results | rituximab | Rheumatoid Arthritis

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0729915
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C0683954
UMLS CUI [2]
C0393022
UMLS CUI [3]
C0003873

Similar models

Eligibility Rheumatoid Arthritis NCT02304354

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Rheumatoid Arthritis
Item
ra according to the american college of rheumatology (acr) criteria
boolean
C0003873 (UMLS CUI [1])
Therapeutic procedure adalimumab
Item
treatment with adalimumab in accordance to the spc
boolean
C0087111 (UMLS CUI [1,1])
C1122087 (UMLS CUI [1,2])
Antirheumatic Drugs, Disease-Modifying
Item
disease modifying anti rheumatic drugs (dmards) prescribed since 3 months and stable 4 weeks before enrollment and during 16 weeks.
boolean
C0242708 (UMLS CUI [1])
Informed consent
Item
signed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
anti-tumor necrosis factor therapy failed | Absent
Item
no anti tnf-alpha failure
boolean
C0281481 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0332197 (UMLS CUI [2])
Prior Therapy rituximab
Item
previous rituximab treatment
boolean
C1514463 (UMLS CUI [1,1])
C0393022 (UMLS CUI [1,2])
Medical contraindication adalimumab | Medical contraindication Methotrexate | Medical contraindication Methylprednisolone
Item
contraindication to adalimumab, methotrexate or methylprednisolone
boolean
C1301624 (UMLS CUI [1,1])
C1122087 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0025677 (UMLS CUI [2,2])
C1301624 (UMLS CUI [3,1])
C0025815 (UMLS CUI [3,2])
Therapy naive Methotrexate
Item
methotrexate-naive patient
boolean
C0919936 (UMLS CUI [1,1])
C0025677 (UMLS CUI [1,2])
Hematological Disease Affecting Lymphocyte | Hematological Disease Affecting Lymphoma
Item
any hematologic disease affecting the lymphocytes (in particular lymphomas)
boolean
C0018939 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0024264 (UMLS CUI [1,3])
C0018939 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0024299 (UMLS CUI [2,3])
Disease osteoarticular Interferes with research results | rituximab | Rheumatoid Arthritis
Item
any osteo-articular disease which could interfere with the interpretation of the influence of the rituximab on ra
boolean
C0012634 (UMLS CUI [1,1])
C0729915 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0683954 (UMLS CUI [1,4])
C0393022 (UMLS CUI [2])
C0003873 (UMLS CUI [3])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial